凯立新材(688269) - 2023 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2023 was ¥370,299,495.36, a decrease of 18.20% compared to the same period last year[5]. - The net profit attributable to shareholders for Q3 2023 was ¥6,561,820.26, down 86.01% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥5,639,861.93, a decline of 87.15% compared to the previous year[5]. - The gross profit margin for the company's precious metal catalyst sales decreased due to high initial inventory costs and a shift in product structure, with the sales revenue from this segment accounting for 90.98% of total revenue[9]. - The net profit margin for the first nine months of 2023 decreased by 44.21% compared to the same period last year, primarily due to declining prices of precious metal raw materials[9]. - Total operating revenue for the first three quarters of 2023 was CNY 1,339,914,386.76, compared to CNY 1,299,544,702.85 in the same period of 2022, reflecting a growth of approximately 3.1%[21]. - Net profit for the first three quarters of 2023 was CNY 97,697,786.01, a decrease from CNY 175,119,880.76 in 2022, representing a decline of approximately 44.3%[22]. - Total comprehensive income for the third quarter was CNY 95,566,529.83, down from CNY 174,615,980.46 in the previous year[23]. - Basic and diluted earnings per share for the third quarter were CNY 0.75, compared to CNY 1.34 in the same period last year[23]. Cash Flow and Assets - The cash flow from operating activities for the year-to-date was ¥46,999,651.29, an increase of 122.31%[6]. - As of September 30, 2023, the company's cash and cash equivalents decreased to ¥199.66 million from ¥460.32 million at the end of 2022, representing a decline of approximately 56.7%[15]. - Total current assets as of September 30, 2023, amounted to ¥817.47 million, down from ¥1.04 billion at the end of 2022, a decrease of approximately 21.5%[15]. - Cash inflow from operating activities for the first three quarters was CNY 1,113,436,620.62, an increase from CNY 1,088,067,623.00 year-over-year[25]. - Cash outflow from investing activities totaled CNY 158,804,778.10, compared to CNY 318,974,362.34 in the same period last year[25]. - Cash flow from financing activities resulted in a net outflow of CNY 149,342,304.17, a decrease from a net inflow of CNY 9,974,852.27 in the previous year[26]. - The company's total assets as of the end of the third quarter of 2023 were CNY 1,454,898,668.26, down from CNY 1,529,217,041.60 at the end of the previous year, a reduction of about 4.9%[17]. - Total liabilities decreased to CNY 480,981,852.81 from CNY 559,373,956.00, showing a decline of approximately 14%[17]. - The company's fixed assets increased to CNY 243,589,678.91 from CNY 104,161,391.27, reflecting a significant growth of about 133.4%[16]. Shareholder Information - The company reported a total of 3,674 common shareholders at the end of the reporting period[12]. - The top 10 shareholders hold a combined 25.7% of the total shares, with the largest shareholder being the Northwest Nonferrous Metal Research Institute, holding 33.6 million shares[12]. Research and Development - Research and development expenses totaled ¥12,625,867.52 for Q3 2023, representing 3.41% of operating revenue, an increase of 0.65 percentage points[6]. - Research and development expenses for the first three quarters of 2023 were CNY 37,507,682.06, slightly down from CNY 38,020,146.06 in 2022, a decrease of about 1.3%[21]. Non-Recurring Items and Other Information - The company reported a total of ¥921,958.33 in non-recurring gains and losses for the current period[8]. - The company has not disclosed any new product developments or technological advancements during the reporting period[14]. - There are no significant mergers or acquisitions reported in the current quarter[14]. - The company has not provided specific future guidance or market expansion strategies in the latest report[14]. - The financial statements for the quarter are unaudited, indicating a need for caution in interpreting the results[14].